FDA OKs Hologic breast imaging workstation

Hologic Inc. has received marketing clearance from the U.S. Food and Drug Administration for its SecurViewDX breast imaging workstation.

The SecurViewDX is a dedicated, multi-modality workstation for display and interpretation of any screening or diagnostic digital mammogram, as well as other images, such as MRI, CT, PET and ultrasound.

Hologic said the workstation also will support digital computer aided detection (CAD) programs.

The SecurViewDX joins Hologic's family of imaging products focused on the early detection of breast cancer and osteoporosis, including the Lorad Selenia full-field digital mammography (FFDM) system, screen-film mammography systems, stereotactic breast biopsy equipment, and an array of bone densitometry products.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup